AnaptysBio, Inc. (ANAB)

54.19 -1.27 (-2.29%) USD  |  NASDAQ  |  Feb 20, 16:00
55.43 +1.24 (+2.29%) Pre-Market: 08:21
More

AnaptysBio Beginning Cash (Quarterly)

Beginning Cash (Quarterly) Chart

View Beginning Cash (Quarterly) for ANAB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Beginning Cash (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Beginning Cash (Quarterly) Range, Past 5 Years

View Beginning Cash (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Beginning Cash (Quarterly) Benchmarks

View Beginning Cash (Quarterly) Benchmarks
Start Trial
Vanda Pharmaceuticals, Inc. Upgrade
Nektar Therapeutics Upgrade
Rigel Pharmaceuticals, Inc. Upgrade
CorMedix, Inc. Upgrade
Verastem, Inc. Upgrade